Provider Utilization of High-Risk Donor Organs and Nucleic Acid Testing: Results of Two National Surveys
Authors:
Open Access
- 1 May 2009
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 9 (5) , 1197-1204
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Formal Policies and Special Informed Consent Are Associated with Higher Provider Utilization of CDC High-Risk Donor OrgansAmerican Journal of Transplantation, 2009
- The high-risk donor: viral infections in solid organ transplantationCurrent Opinion in Organ Transplantation, 2008
- The Risk of HIV, HBV, HCV and HTLV Infection Among Musculoskeletal Tissue Donors in AustraliaAmerican Journal of Transplantation, 2007
- Screening of HIV infection: role of molecular and immunological assaysExpert Review of Molecular Diagnostics, 2006
- HIV and hepatitis C virus RNA in seronegative organ and tissue donorsThe Lancet, 2004
- False-Positive Results and Contamination in Nucleic Acid Amplification Assays: Suggestions for a Prevent and Destroy StrategyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Elimination of false-negative hepatitis C virus RNA results by removal of inhibitors in cadaver-organ donor blood specimensTransplantation, 2003
- HIV infection in the first heart transplantation in Italy: fatal outcomeAPMIS, 1998
- LONG-TERM FOLLOW-UP OF HEPATITIS C VIRUS INFECTION AMONG ORGAN TRANSPLANT RECIPIENTSTransplantation, 1997
- "Occult" hepatitis B virus as source of infection in liver transplant recipientsThe Lancet, 1994